DK1048668T3 - Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater - Google Patents

Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater

Info

Publication number
DK1048668T3
DK1048668T3 DK00108560T DK00108560T DK1048668T3 DK 1048668 T3 DK1048668 T3 DK 1048668T3 DK 00108560 T DK00108560 T DK 00108560T DK 00108560 T DK00108560 T DK 00108560T DK 1048668 T3 DK1048668 T3 DK 1048668T3
Authority
DK
Denmark
Prior art keywords
spray drying
riboflavin
drying process
spray granules
containing spray
Prior art date
Application number
DK00108560T
Other languages
Danish (da)
English (en)
Inventor
Markus Nowotny
Jean-Claude Tritsch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8238078&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1048668(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK1048668T3 publication Critical patent/DK1048668T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/06—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of pills, lozenges or dragees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/12—Heterocyclic compounds containing pteridine ring systems containing pteridine ring systems condensed with carbocyclic rings or ring systems
    • C07D475/14—Benz [g] pteridines, e.g. riboflavin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK00108560T 1999-04-30 2000-04-19 Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater DK1048668T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99108476 1999-04-30

Publications (1)

Publication Number Publication Date
DK1048668T3 true DK1048668T3 (da) 2003-05-26

Family

ID=8238078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00108560T DK1048668T3 (da) 1999-04-30 2000-04-19 Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater

Country Status (16)

Country Link
US (1) US6723346B1 (pt)
EP (1) EP1048668B2 (pt)
JP (1) JP4965013B2 (pt)
KR (1) KR100720202B1 (pt)
CN (1) CN1198595C (pt)
AT (1) ATE231864T1 (pt)
AU (1) AU770320B2 (pt)
BR (1) BR0002390A (pt)
CA (1) CA2306502A1 (pt)
DE (1) DE60001286T3 (pt)
DK (1) DK1048668T3 (pt)
ES (1) ES2189711T5 (pt)
ID (1) ID25698A (pt)
MX (1) MXPA00004185A (pt)
NO (1) NO318219B1 (pt)
TW (1) TWI253347B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0219815D0 (en) * 2002-08-24 2002-10-02 Accentus Plc Preparation of small crystals
DE10317051A1 (de) * 2003-04-11 2004-10-21 Basf Ag Verfahren zur Herstellung von Riboflavin der Modifikation B/C in Granulatform
ES2332787T3 (es) * 2003-07-22 2010-02-12 Dsm Ip Assets B.V. Procedimiento para la purificacion de rivoflavina.
EP2107934B1 (en) * 2006-12-07 2019-11-20 FrieslandCampina Nederland B.V. Method and apparatus for spray drying
CN104961740B (zh) * 2015-06-02 2016-04-27 湖北广济药业股份有限公司 一种含核黄素的固体制剂及其制备方法
BR112021008614A2 (pt) 2018-11-07 2021-11-03 Dsm Ip Assets Bv Medicamentos que contêm riboflavina que exibem fluidez aprimorada

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE91686T1 (de) * 1987-09-18 1993-08-15 Hoffmann La Roche Neue form des riboflavins.
DE3819745A1 (de) * 1988-06-10 1989-12-14 Basf Ag Verfahren zur herstellung von auf mikrobiellem wege hergestelltem riboflavin in form von sprueh- oder mikrogranulaten
JP2634285B2 (ja) * 1989-03-28 1997-07-23 積水化学工業株式会社 放射性物質取扱所の被覆材用非灰分性樹脂組成物
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
US5236920A (en) * 1990-04-30 1993-08-17 Basf Corporation Granulated riboflavin product having high flowability, high riboflavin content
US4994458A (en) * 1990-04-30 1991-02-19 Basf Corporation Process for rotary fluid bed granulation of riboflavin
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
US5000888A (en) * 1990-05-23 1991-03-19 Basf Corporation Process for spray drying riboflavin to produce a granulate product having low binder content
JP2000112883A (ja) * 1998-09-24 2000-04-21 Internatl Business Mach Corp <Ibm> 情報処理方法、情報処理装置、情報処理プログラムを格納する記憶媒体
CA2282908A1 (en) 1998-10-19 2000-04-19 F. Hoffmann-La Roche Ag Purification and crystallization process for riboflavin
US6093715A (en) * 1999-03-24 2000-07-25 Basf Aktiengesellschaft Process for producing riboflavin-containing granules

Also Published As

Publication number Publication date
DE60001286T3 (de) 2010-10-28
NO318219B1 (no) 2005-02-21
JP2000327562A (ja) 2000-11-28
MXPA00004185A (es) 2002-03-08
CN1198595C (zh) 2005-04-27
KR20010029668A (ko) 2001-04-06
JP4965013B2 (ja) 2012-07-04
ATE231864T1 (de) 2003-02-15
NO20002283L (no) 2000-10-31
CA2306502A1 (en) 2000-10-30
NO20002283D0 (no) 2000-04-28
ID25698A (id) 2000-11-02
EP1048668B2 (en) 2010-06-09
EP1048668A3 (en) 2001-03-28
DE60001286T2 (de) 2003-11-06
AU3018900A (en) 2000-11-02
DE60001286D1 (de) 2003-03-06
EP1048668A2 (en) 2000-11-02
BR0002390A (pt) 2000-10-31
ES2189711T3 (es) 2003-07-16
AU770320B2 (en) 2004-02-19
EP1048668B1 (en) 2003-01-29
KR100720202B1 (ko) 2007-05-21
CN1275375A (zh) 2000-12-06
US6723346B1 (en) 2004-04-20
ES2189711T5 (es) 2010-07-28
TWI253347B (en) 2006-04-21

Similar Documents

Publication Publication Date Title
SI1155015T1 (sl) Postopek za proizvodnjo terc.-butil (E)-(6-(2-(4-(4-fluorofenil)-6- izopropil-2-(metil(metilsulfonil)amino)pirimidin-5-il)vinil)(4R,6S)-2, 2-dimetil-(1,3)dioksan-4-il)acetata
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
NO20041886L (no) Fremgangsmate for fremstilling av maursyreformiater
FI102069B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolijohdannaisten valmist amiseksi
WO2008079683A3 (en) N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
DE3863328D1 (de) Granuliertes produkt.
DK1048668T3 (da) Fremgangsmåde til fremstilling af riboflavinholdige spraygranulater
WO1992020649A3 (en) Substituted 2-carboxyindoles having pharmaceutical activity
DK0626961T3 (da) Fremgangsmåde til nitrosering
CN101421254B (zh) 用双环基团n-取代的二氨基-1，3，5-三嗪、其制备方法、其组合物及其用作除草剂和植物生长调节剂的用途
DK0717042T3 (da) Fremgangsmåde til fremstilling af 1-(4,5-dihydro-2-thiazolyl)-3-azetidin-thiol-derivater
DE69833951D1 (de) Verfahren zur herstellung von substituierten alkylaminen oder salzen davon
EE03873B1 (et) Meetod alküüloksüfuranooni amiinderivaatide valmistamiseks, sel meetodil saadud ühendid ja nende kasutamine
NO20005103D0 (no) Nye cyanoindol serotonin-reopptaks-inhibitorforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
HUP0300505A2 (en) Process for the preparation of acylated 1,3-dicarbonyl compounds
WO2003004464A8 (de) Heterozyklische amidderivate und deren verwendung als schädlingsbekämpfungsmittel
WO2005065655A3 (de) Verfahren zur herstellung von keto-l-gulonsäuresprühgranulaten
PT1325740E (pt) Granulados estaveis contendo s-adenosilmetionina e processo para a preparacao dos mesmos
AU2002352097A1 (en) Method for producing bleach activator granules
TH45468A (th) กระบวนการสำหรับการเตรียมวัสดุเม็ดหยาบสำหรับสเปรย์ซึ่งมีริโบฟลาวิน
NO20040423L (no) Salter av substituerte 1,2,3,4-tetrahydroisokinolin-2-karboksylsyrederivater.
FI990697A (fi) Menetelmä hydrofobisen turverakeen valmistamiseksi
NO20013453D0 (no) Fremgangsmåte for fremstilling av salter av cyanobenzylaminer
JPS5555165A (en) N-(benzoylmercapto substituted acyl)-histidine